Oral coronavirus vaccine candidate enters clinical trial

In addition to offering an alternative to those who fear or dislike needles, the company is hopeful that a tablet form of a vaccine will help to address some of the mass distribution concerns.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.